Anti TGF-β: An open trial with losartan, an angiotensin II receptor blocker that inhibits TGF-β1, is underway in patients with EoE (NCT0180816 www.clinicaltrials.gov) (158). The gene discussed is TGFB1; the disease is eosinophilic esophagitis.